Back to News
Dec 3, 2025 4:00 PM

CVS Accused Of Years Of Faulty Insulin Refills In $37.8 Million Settlement

Federal prosecutors on Tuesday said Jay Clayton, the U.S. attorney for the Southern District of New York, alleged that CVS Health Inc. (NYSE:CVS) engaged in a years-long pattern of improper billing tied to insulin pens dispensed to patients in federal healthcare programs.

Officials from multiple federal oversight agencies said the company repeatedly sought reimbursement for refills that were either unnecessary, premature, or inaccurately reported, ultimately leading to a multimillion-dollar settlement.

The United States filed and simultaneously settled a civil healthcare fraud lawsuit against CVS Pharmacy, Inc., resolving allegations that the company violated the False Claims Act between 2010 ...